Last reviewed · How we verify
NCT06598709: EXTEND ARDS
International Survey for EXTubation Evaluation and Respiratory Dynamics in Acute Respiratory Distress Syndrome
trial in ARDS (Acute Respiratory Distress Syndrome) in 1,000 participants. Enrolling by invitation.
31 October 2025
Quick facts
| Lead sponsor | Hiroshima University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 November 2024 |
| Primary completion | 31 October 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Japan |
Conditions studied
- ARDS (Acute Respiratory Distress Syndrome) — all drugs for ARDS (Acute Respiratory Distress Syndrome) →
Sponsor
Hiroshima University
Who can join
16 and older, any sex, with ARDS (Acute Respiratory Distress Syndrome). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
EXTEND ARDS study is an international survey for ventilator weaning and extubation among ARDS patients. This study will be conducted on behalf of the Japanese ARDS Clinical Practice Guideline 2024 Committee as well as endorsement of the Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine. This survey aims to prospectively collect the clinical data of mechanically ventilated ARDS patients related with ventilator weaning and extubation internationally as well as the outcome of ARDS patients with extubation failure. This study also aims to identify predictive factors strongly associated with extubation failure. The contents of mechanical ventilation settings, respiratory conditions, and blood examination data will be collected.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06598709
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ARDS (Acute Respiratory Distress Syndrome)
Currently open trials in the same condition.
- NCT06990477 — Effect of EIT-guided PEEP in ARDS Patients With Higher Recruitability · NA · recruiting
- NCT07125079 — Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be M · recruiting
- NCT06911450 — Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations · recruiting
- NCT06734988 — EXTEND ARDS-J Esophageal Pressure Study · recruiting
- NCT06790875 — Effects of Low Tidal Volume and Airway Pressure Release Ventilation on Lung Tissue Mechanics in ARDS Patients Under Mech · NA · recruiting
Other Hiroshima University trials
Trials by the same sponsor.
- NCT07527429 — Procedure Manual-Based Simulation Training to Improve Operating Room Nurses' Core Competencies · NA · not yet recruiting
- NCT07299799 — Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central · NA · not yet recruiting
- NCT07384650 — Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh · NA · recruiting
- NCT07310680 — Impact of mHealth Education on Hemoglobin Level Among Pregnant Women With Anemia in Rural Bangladesh. · NA · not yet recruiting
- NCT06871553 — The Self-management Program on Hemodialysis Patients in Cambodia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06598709 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hiroshima University
- Last refreshed: 20 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06598709.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing